Identification of subjects with locally advanced lung cancer who are likely to respond to standard-of-care chemoradiotherapy by a longitudinal monitoring of circulating tumor DNA (ctDNA) using a comprehensive ultra-sensitive NGS assay

Autor:	M. Heibeck, Boe Sandahl Sorensen, Anne Tranberg Madsen, E. Kwok, Aarthi Balasubramanyam, Stephanie J. Yaung, Dan Klass, Liu Xi, John F. Palma, Peter Meldgaard, Michelle Simone Clement, K. Probst, Alex Lovejoy, Nalin Tikoo, Patrik Vitazka, E. Meldgaard, A. Rehfeldt
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty Standard of care business.industry Locally advanced Hematology medicine.disease Circulating tumor DNA Internal medicine medicine Identification (biology) Lung cancer business Chemoradiotherapy Ultra sensitive
Zdroj:	Annals of Oncology. 29:viii491
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy291.010
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::521d35888ad6843b6ec6456350d27817 https://doi.org/10.1093/annonc/mdy291.010 Zobrazit plný text záznamu